Ask a Guide Anything
May 8, 2026
[3-min read] Facilitators share how their own psilocybin use has shaped their approach.
This Week in Psychedelics
May 6, 2026
[5-min read] New study compares 2C-B to psilocybin and MDMA in healthy volunteers.
Psychonaut POV
May 3, 2026
[6-min read] Q&A with Gül Dölen, Neurobiologist
May 1, 2026
[3-min read] Psilocybin facilitators explain how they address memory loss and cognitive decline.
Apr 29, 2026
[5-min read] FDA awards priority vouchers to Compass, Otsuka, and Usona.
Apr 26, 2026
[5-min read] Q&A with Steve Levine, Chief Patient Officer
Apr 22, 2026
[5-min read] Trump signs executive order to accelerate psychedelic research and access.
Apr 19, 2026
[5-min read] Q&A with Robert Gallery, Former NFL Lineman
Apr 17, 2026
[3-min read] Facilitators demystify how the medicine starts working before you take it.
Apr 15, 2026
[5-min read] New study examines MDMA's effects on male reproductive biology.
Apr 12, 2026
[5-min read] Q&A with Rebekah Senānāyaka, Ethnobotanist & Psychologist
Apr 10, 2026
[3-min read] Facilitators explain what to do when partners integrate differently.
Apr 8, 2026
[5-min read] Texas plans to move ibogaine initiative forward without a drug company.
Apr 5, 2026
[5-min read] Q&A with Keith Kurlander, Therapist & Author
Apr 3, 2026
[3-min read] Facilitators explain how to prepare your nervous system for psilocybin.
Apr 1, 2026
[5-min read] Otsuka agrees to acquire Transcend Therapeutics for $1.225 billion.
Mar 29, 2026
[5-min read] Q&A with Daniel Shankin, Founder & Integration Coach
Mar 27, 2026
[3-min read] Psychedelic facilitators explain what can go wrong and how to handle it.
Mar 25, 2026
[5-min read] 24-trial review suggests psychedelics are no more effective than antidepressants.
